# Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.

> **NCT01128582** · PHASE3 · UNKNOWN · sponsor: **Southern Arizona VA Health Care System** · enrollment: 40 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease
- Chronic Insomnia

## Interventions

- **DRUG:** Rozerem (ramelteon)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01128582
- **Lead sponsor:** Southern Arizona VA Health Care System
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-03
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128582, "Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01128582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*